ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

MNKD Company Profile and Key Details

NASDAQ : MNKD

MannKind Corporation

$4.62

-0.07-1.49%

At Close 4:00 PM

57.88

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

MNKD Stock Price Chart

Stock Price Today

MannKind Corporation (MNKD) stock declined over -1.49%, trading at $4.62 on NASDAQ, down from the previous close of $4.69. The stock opened at $4.84, fluctuating between $4.57 and $4.85 in the recent session.

Stock Snapshot

4.69

Prev. Close

4.84

Open

1.4B

Market Cap

303.86M

Number of Shares

4.57

Day Low

4.8499

Day High

46.2

P/E Ratio

97.09%

Free Float in %

0.1

EPS (TTM)

-0.91

Book Value

-0.03

Cash Flow per Share

2.33M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 08, 2025	4.58	4.85	4.57	4.62	2.33M
Apr 07, 2025	4.56	4.94	4.51	4.69	3.81M
Apr 04, 2025	4.77	4.87	4.72	4.74	3.02M
Apr 03, 2025	4.92	5.00	4.83	4.88	2.14M
Apr 02, 2025	4.90	5.05	4.88	5.02	1.73M
Apr 01, 2025	5.03	5.08	4.91	4.95	2.88M
Mar 31, 2025	4.96	5.06	4.89	5.04	2.64M
Mar 28, 2025	5.09	5.12	5.00	5.03	1.3M
Mar 27, 2025	5.05	5.11	5.02	5.10	1.32M
Mar 26, 2025	5.21	5.22	5.05	5.06	1.32M
Mar 25, 2025	5.22	5.27	5.16	5.22	1.58M
Mar 24, 2025	5.23	5.28	5.20	5.23	1.32M
Mar 21, 2025	5.23	5.23	5.16	5.22	2.51M
Mar 20, 2025	5.30	5.44	5.23	5.26	2.08M
Mar 19, 2025	5.19	5.32	5.18	5.32	1.42M
Mar 18, 2025	5.22	5.27	5.15	5.21	1.3M
Mar 17, 2025	5.18	5.29	5.16	5.24	1.9M
Mar 14, 2025	5.20	5.30	5.16	5.20	1.62M
Mar 13, 2025	5.19	5.30	5.06	5.15	1.53M
Mar 12, 2025	5.24	5.29	5.14	5.22	2.13M

Contact Details

Westlake Village, CA 91362

United States

Website: https://www.mannkindcorp.comContact: 818 661 5000

About Company

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

Frequently Asked Questions

What is the current MannKind Corporation (MNKD) stock price?

MannKind Corporation (NASDAQ: MNKD) stock price is $4.62 in the last trading session. During the trading session, MNKD stock reached the peak price of $4.85 while $4.57 was the lowest point it dropped to. The percentage change in MNKD stock occurred in the recent session was -1.49% while the dollar amount for the price change in MNKD stock was -$0.07.

MNKD's industry and sector of operation?

The NASDAQ listed MNKD is part of Biotechnology industry that operates in the broader Healthcare sector. MannKind Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MNKD?

Ms. Rosabel Realica Alinaya
Vice President of Investor Relations & Treasury
Mr. John F. Bedard
Senior Vice President of Worldwide Regulatory Affairs
Mr. James Patrick McCauley Jr., J.D., M.B.A.
Chief Commercial Officer
Dr. Stuart A. Tross Ph.D.
Executive Vice President and Chief People & Workplace Officer
Mr. Joseph Kocinsky M.B.A., M.S.
Chief Technology Officer
Dr. Michael E. Castagna Pharm.D.
Chief Executive Officer & Director
Mr. Steven B. Binder
Chief Financial Officer
Dr. David B. Thomson
Executive Vice President, Gen. Counsel & Sec.
Mr. Sanjay Singh M.B.A.
Executive Vice President of Technical Operations
Ms. Lauren M. Sabella
Executive Vice President & Chief Operating Officer
Mr. Thomas Hofmann M.D., Ph.D.
Senior Vice President & Chief Scientific Officer

How MNKD did perform over past 52-week?

MNKD's closing price is 16.37% higher than its 52-week low of $3.97 where as its distance from 52-week high of $7.63 is -39.45%.

How many employees does MNKD have?

Number of MNKD employees currently stands at 403.

Link for MNKD official website?

Official Website of MNKD is: https://www.mannkindcorp.com

How do I contact MNKD?

MNKD could be contacted at phone 818 661 5000 and can also be accessed through its website. MNKD operates from 30930 Russell Ranch Road, Westlake Village, CA 91362, United States.

How many shares of MNKD are traded daily?

MNKD stock volume for the day was 2.33M shares. The average number of MNKD shares traded daily for last 3 months was 2.1M.

What is the market cap of MNKD currently?

The market value of MNKD currently stands at $1.40B with its latest stock price at $4.62 and 303.86M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	403
Beta	1.26
Sales or Revenue	$198.96M
5Y Sales Change%	2.855%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology